ArticleScientific reports2026
Antimicrobial and anticancerogenic activity of selenium nanoparticles obtained via pulsed laser ablation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
SeNPs were synthesized via chemical reduction and physical pulsed laser ablation techniques. Stable, spherical nanoparticles with TEM diameters ranging from 20 to 150 nm (mean ± SD: 28.5 ± 7.2 nm and 33.8 ± 6.4 nm for the chemical and physical methods, respectively) were obtained. The characteristic absorption peaks at 310 nm and 371 nm were detected for SeNPs produced by chemical reduction and physical pulsed laser ablation, respectively. The band gap values were found to be 1.74 eV and 1.92 eV, respectively. Zeta potential analysis confirmed moderate colloidal stability (23.67 mV and 25.17 mV for chemical and physical reduction, respectively). The antibacterial activities of the SeNPs against E. coli, Klebsiella spp., Pseudomonas spp. and Staphylococcus spp. were evaluated using the agar well diffusion method. SeNPs synthesized by the chemical reduction method formed inhibition zones of 10, 14, 18, 20 and 27 mm (E. coli); 9-18 mm (Staphylococcus spp.); 10-17 mm (Klebsiella spp.); and 8-16 mm (Pseudomonas spp.). Particles synthesized by physical pulsed laser ablation formed equivalent zones of 9-24 mm, 8-16 mm, 9-17 mm, and 7-15 mm. A particularly notable result was the strain- and dose-dependent difference identified by one-way ANOVA (F = 3304.3, p < 1 × 10⁻
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.